Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year

ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13555-021-00657-y) contains supplementary material, which is available to authorized users.

Detalles Bibliográficos
Autores principales: Blauvelt, Andrew, de Bruin-Weller, Marjolein, Simpson, Eric L., Chen, Zhen, Ardeleanu, Marius, Rossi, Ana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776905/
https://www.ncbi.nlm.nih.gov/pubmed/34994968
http://dx.doi.org/10.1007/s13555-021-00657-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776905/
https://www.ncbi.nlm.nih.gov/pubmed/34994968
http://dx.doi.org/10.1007/s13555-021-00657-y

Ejemplares similares